On 28th February 2023, Stayble Therapeutics AB announced that the Company received approval
CROMSOURCE Regulatory Newsletter October – December 2022
CROMSOURCE announces publication of its latest Regulatory Newsletter summarising important
CROMSOURCE Regulatory Newsletter July – September 2022
CROMSOURCE announces publication of its latest Regulatory Newsletter summarising important
CROMSOURCE Regulatory Newsletter April – June 2022
CROMSOURCE announces publication of its latest Regulatory Newsletter summarising important
CROMSOURCE Celebrates 25 Years – Dedicated to Clinical Research Solutions since 1997
In July 2022 CROMSOURCE marks its 25th anniversary of delivering innovative, high quality
- 1
- 2
- 3
- …
- 6
- Next Page »